| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9382 |
| Human Intestinal Absorption | HIA+ | 0.9957 |
| Caco-2 Permeability | Caco2+ | 0.8663 |
| P-glycoprotein Substrate | Non-substrate | 0.7386 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8908 |
| Non-inhibitor | 0.9585 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8022 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6249 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7689 |
| CYP450 2D6 Substrate | Non-substrate | 0.7874 |
| CYP450 3A4 Substrate | Non-substrate | 0.5135 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5364 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9765 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8687 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8691 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9433 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8113 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9313 |
| Non-inhibitor | 0.8935 |
| AMES Toxicity | Non AMES toxic | 0.9220 |
| Carcinogens | Non-carcinogens | 0.5233 |
| Fish Toxicity | Low FHMT | 0.6442 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7999 |
| Honey Bee Toxicity | Low HBT | 0.5170 |
| Biodegradation | Not ready biodegradable | 0.8176 |
| Acute Oral Toxicity | II | 0.5394 |
| Carcinogenicity (Three-class) | Non-required | 0.6199 |